Colorectal Cancer, Liver Metastases and Biotherapies

Bibliographic Details
Title: Colorectal Cancer, Liver Metastases and Biotherapies
Authors: Daniel-Clement Osei-Bordom, Sivesh Kamarajah, Niki Christou
Source: Biomedicines, Vol 9, Iss 8, p 894 (2021)
Publisher Information: MDPI AG, 2021.
Publication Year: 2021
Collection: LCC:Biology (General)
Subject Terms: colorectal cancer, liver metastases, immunotherapy, chemotherapy and biological agents, Biology (General), QH301-705.5
More Details: (1) Background: colorectal cancer (CRC) is one of the deadliest causes of death by cancer worldwide. Its first main metastatic diffusion spreads to the liver. Different mechanisms such as the epithelial–mesenchymal transition and angiogenesis are the characteristics of this invasion. At this stage, different options are possible and still in debate, especially regarding the use of targeted therapeutics and biotherapies. (2) Methods: A review of the literature has been done focusing on the clinical management of liver metastasis of colorectal cancer and the contribution of biotherapies in this field. (3) Results: In a clinical setting, surgeons and oncologists consider liver metastasis in CRC into two groups to launch adapted therapeutics: resectable and non-resectable. Around these two entities, the combination of targeted therapies and biotherapies are of high interest and are currently tested to know in which molecular and clinical conditions they have to be applied to impact positively both on survival and quality of life of patients.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2227-9059
Relation: https://www.mdpi.com/2227-9059/9/8/894; https://doaj.org/toc/2227-9059
DOI: 10.3390/biomedicines9080894
Access URL: https://doaj.org/article/24eb572b17854b908e545da4ecc9676a
Accession Number: edsdoj.24eb572b17854b908e545da4ecc9676a
Database: Directory of Open Access Journals
More Details
ISSN:22279059
DOI:10.3390/biomedicines9080894
Published in:Biomedicines
Language:English